Cargando…
LRH-1 drives hepatocellular carcinoma partially through induction of c-myc and cyclin E1, and suppression of p21
BACKGROUND: To explore potential therapeutic target is one of the areas of great interest in both clinical and basic hepatocellular carcinoma (HCC) studies. Nuclear receptor liver receptor homolog-1 (LRH-1, NR5A2) is proved to play a positive role in several cancers including breast cancer, pancreat...
Autores principales: | Xiao, Lijia, Wang, Yuliang, Liang, Weicheng, Liu, Liping, Pan, Nannan, Deng, Huimin, Li, Luqian, Zou, Chang, Chan, Franky Leung, Zhou, Yiwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078084/ https://www.ncbi.nlm.nih.gov/pubmed/30122988 http://dx.doi.org/10.2147/CMAR.S162887 |
Ejemplares similares
-
LRH-1-dependent programming of mitochondrial glutamine processing drives liver cancer
por: Xu, Pan, et al.
Publicado: (2016) -
Human FXR Regulates SHP Expression through Direct Binding to an LRH-1 Binding Site, Independent of an IR-1 and LRH-1
por: Hoeke, Martijn O., et al.
Publicado: (2014) -
Identification of transcription factors and single nucleotide polymorphisms of Lrh1 and its homologous genes in Lrh1-knockout pancreas of mice
por: Tang, Maochun, et al.
Publicado: (2014) -
Enantiomer-specific activities of an LRH-1 and SF-1 dual agonist
por: Mays, Suzanne G., et al.
Publicado: (2020) -
Antidiabetic actions of a phosphatidylcholine ligand for nuclear receptor LRH-1
por: Lee, Jae Man, et al.
Publicado: (2011)